Vagus nerve stimulation enhances remyelination and decreases innate neuroinflammation in lysolecithin-induced demyelination
Bachmann H, Vandemoortele B, Vermeirssen V, Carrette E, Vonck K, Boon P, Raedt R, Laureys G
Brain Stimulation · 2024
Key finding
Immunohistochemistry showed that cVNS significantly reduced microglial and astrocytic activation in the lesion and lesion border, and significantly reduced the Olig2+ cell count at 3 dpi.
- Condition
- Multiple Sclerosis
- Stimulation
- taVNS
- Evidence tier
- Controlled Clinical Trial
- Participants
- —
Cite this study
Bachmann, H., Vandemoortele, B., Vermeirssen, V., Carrette, E., Vonck, K., Boon, P., Raedt, R., & Laureys, G. (2024). Vagus nerve stimulation enhances remyelination and decreases innate neuroinflammation in lysolecithin-induced demyelination. Brain Stimulation, 17(3), 575-587. https://doi.org/10.1016/j.brs.2024.04.012
Related studies in Multiple Sclerosis
The Vagus Nerve Somatosensory-evoked Potential in Neural Disorders: Systematic Review and Illustrative Vignettes
Leon-Ariza et al. · Clinical EEG and neuroscience · 2022 · Systematic Review / Meta-Analysis
Effect of non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) on non-motor symptoms in multiple sclerosis: study protocol for a randomised, controlled trial
Herr et al. · BMJ open · 2025 · Randomised Controlled Trial
Effect of non-invasive transcutaneous auricular vagus nerve stimulation on cerebral motor excitability-Study protocol for a randomized, sham controlled trial
Herr et al. · Frontiers in neurology · 2023 · Randomised Controlled Trial
Paired vagus nerve stimulation drives precise remyelination and motor recovery after myelin loss
Huang et al. · bioRxiv : the preprint server for biology · 2024 · Controlled Clinical Trial
Summary by Vagus Research. Always consult the primary source for the authoritative record.